Top

Published in:

Open Access 30-07-2024 | Obesity | Review

Diagnosis and Management of Hypertension in Adolescents with Obesity

Authors: Shradha M. Chhabria, Jared LeBron, Sarah D. Ronis, Courtney E. Batt

Published in: Current Cardiovascular Risk Reports | Issue 8-9/2024

Abstract

Purpose of Review

Hypertension (HTN) and obesity are increasing in prevalence and severity in adolescents and have significant implications for long term morbidity and mortality. This review focuses on the diagnosis and management of HTN in adolescents with obesity with an emphasis on co-management of the two conditions.

Recent Findings

Recent studies affirm the increasing prevalence of abnormal blood pressures and diagnoses of HTN associated with increased adiposity. Current guidelines recommend routine screening with proper technique for HTN in patients with obesity. Additionally, obesity and HTN related co-occurring medical conditions should be evaluated as there is frequently a bidirectional impact on risk and outcomes. Importantly, advances in adolescent obesity management have subsequently led to positive implications for the management of obesity-related comorbidities such as HTN. The co-management of obesity and HTN is an emerging strategy for treatment and prevention of additional morbidity and mortality as patients progress to adulthood.

Summary

In adolescent patients with obesity, prompt recognition and appropriate diagnosis of HTN as well as related co-occurring conditions are necessary first steps in management. Co-management of obesity and HTN is likely to lead to improved outcomes. While lifestyle interventions serve as the foundation to this management, adjunctive and emerging therapies should be considered to adequately treat both conditions.

Alpert BS, Quinn D, Gallick D. Oscillometric blood pressure: a review for clinicians. J Am Soc Hyperten: JASH. 2014;8(12):930–8. https://doi.org/10.1016/j.jash.2014.08.014.CrossRef

Barr DA. The childhood roots of cardiovascular disease disparities. Mayo Clin Proc. 2017;92(9):1415–21. https://doi.org/10.1016/j.mayocp.2017.06.013.CrossRefPubMed

Bijlsma MW, Blufpand HN, Kaspers GJL, Bökenkamp A. Why pediatricians fail to diagnose hypertension: a multicenter survey. J Pediatr. 2014;164(1):173-177.e7. https://doi.org/10.1016/j.jpeds.2013.08.066.CrossRefPubMed

Binka E, Brady TM. Real-world strategies to treat hypertension associated with pediatric obesity. Curr Hypertens Rep. 2019;21(2):18. https://doi.org/10.1007/s11906-019-0922-2.CrossRefPubMedPubMedCentral

Boneparth A, Flynn JT. Evaluation and treatment of hypertension in general pediatric practice. Clin Pediatr. 2009;48(1):44–9. https://doi.org/10.1177/0009922808321677.CrossRef

Brady TM, Solomon BS, Neu AM, Siberry GK, Parekh RS. Patient-, provider-, and clinic-level predictors of unrecognized elevated blood pressure in children. Pediatrics. 2010;125(6):e1286–93. https://doi.org/10.1542/peds.2009-0555.CrossRefPubMed

Brzeziński M, Metelska P, Myśliwiec M, Szlagatys-Sidorkiewicz A. Lipid disorders in children living with overweight and obesity- large cohort study from Poland. Lipids Health Dis. 2020;19(1):47. https://doi.org/10.1186/s12944-020-01218-6.CrossRefPubMedPubMedCentral

Calcaterra V, Rossi V, Mari A, Casini F, Bergamaschi F, Zuccotti GV, Fabiano V. Medical treatment of weight loss in children and adolescents with obesity. Pharmacol Res. 2022;185(November):106471. https://doi.org/10.1016/j.phrs.2022.106471.CrossRefPubMed

Cheung EL, Bell CS, Samuel JP, Poffenbarger T, Redwine KM, Samuels JA. Race and obesity in adolescent hypertension. Pediatrics. 2017;139(5):e20161433. https://doi.org/10.1542/peds.2016-1433.CrossRefPubMedPubMedCentral

10.

Chuang H-H, Hsu J-F, Wang C-Y, Chuang L-P, Chen M-C, Chen N-H, Huang Y-S, Li H-Y, Lee L-A. Hypertension in children with obstructive sleep apnea syndrome-age, weight status, and disease severity. Int J Environ Res Public Health. 2021;18(18):9602. https://doi.org/10.3390/ijerph18189602.CrossRefPubMedPubMedCentral

11.

Couch SC, Saelens BE, Khoury PR, Dart KB, Hinn K, Mitsnefes MM, Daniels SR, Urbina EM. Dietary approaches to stop hypertension dietary intervention improves blood pressure and vascular health in youth with elevated blood pressure. Hypertension. 2021;77(1):241–51. https://doi.org/10.1161/HYPERTENSIONAHA.120.16156.CrossRefPubMed

12.

Couch SC, Saelens BE, Levin L, Dart K, Falciglia G, Daniels SR. The efficacy of a clinic-based behavioral nutrition intervention emphasizing a DASH-type diet for adolescents with elevated blood pressure. J Pediatr. 2008;152(4):494–501. https://doi.org/10.1016/j.jpeds.2007.09.022.CrossRefPubMed

13.

Crowell JA, Davis CR, Joung KE, Usher N, McCormick S-P, Dearing E, Mantzoros CS. Metabolic pathways link childhood adversity to elevated blood pressure in midlife adults. Obes Res Clin Pract. 2016;10(5):580–8. https://doi.org/10.1016/j.orcp.2015.10.009.CrossRefPubMed

14.

Di Bonito P, Licenziati MR, Morandi A, Maffeis C, Miraglia Del Giudice E, Di Sessa A, Campana G, Wasniewska M, Corica D, Valerio G. Screening for hypertension in young people with obesity: feasibility in the real life. Nutr Metab Cardiovasc Dis. 2022;32(5):1301–7. https://doi.org/10.1016/j.numecd.2022.02.001.CrossRefPubMed

15.

East P, Doom J, Delker E, Blanco E, Burrows R, Correa-Burrows P, Lozoff B, Gahagan S. Childhood socioeconomic hardship, family conflict, and young adult hypertension: the santiago longitudinal study. Soc Sci Med. 2020;253(May):112962. https://doi.org/10.1016/j.socscimed.2020.112962.CrossRefPubMedPubMedCentral

16.

Eslam M, Sanyal AJ, George J, Sanyal A, Neuschwander-Tetri B, Tiribelli C, Kleiner DE, et al. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999-2014.e1. https://doi.org/10.1053/j.gastro.2019.11.312.CrossRefPubMed

17.

Flynn JT, Falkner BE. Obesity hypertension in adolescents: epidemiology, evaluation, and management. J Clin Hyperten. 2011;13(5):323–31. https://doi.org/10.1111/j.1751-7176.2011.00452.x.CrossRef

18.

Flynn JT, Falkner BE. New clinical practice guideline for the management of high blood pressure in children and adolescents. Hypertension. 2017;70(4):683–6. https://doi.org/10.1161/HYPERTENSIONAHA.117.10050.CrossRefPubMed

19.

Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3):e20171904. https://doi.org/10.1542/peds.2017-1904.CrossRefPubMed

20.

Fox CK, Marlatt KL, Rudser KD, Kelly AS. Topiramate for weight reduction in adolescents with severe obesity. Clin Pediatr. 2015;54(1):19–24. https://doi.org/10.1177/0009922814542481.CrossRef

21.

Garner A, Yogman M. Preventing childhood toxic stress: partnering with families and communities to promote relational health. Pediatrics. 2021;148(2):e2021052582. https://doi.org/10.1542/peds.2021-052582.CrossRefPubMed

22.

Gishti O, Jaddoe VWV, Felix JF, Klaver CCW, Hofman A, Wong TY, Ikram MK, Gaillard R. Retinal microvasculature and cardiovascular health in childhood. Pediatrics. 2015;135(4):678–85. https://doi.org/10.1542/peds.2014-3341.CrossRefPubMed

23.

Grandone A, Santoro N, Coppola F, Calabrò P, Perrone L, Giudice EMD. Thyroid function derangement and childhood obesity: an italian experience. BMC Endocr Disord. 2010;10(1):8. https://doi.org/10.1186/1472-6823-10-8.CrossRefPubMedPubMedCentral

24.

Hagman E, Danielsson P, Elimam A, Marcus C. The effect of weight loss and weight gain on blood pressure in children and adolescents with obesity. Int J Obes. 2019;43(10):1988–94. https://doi.org/10.1038/s41366-019-0384-2.CrossRef

25.

Halbach SM, Flynn J. Treatment of obesity-related hypertension in children and adolescents. Curr Hypertens Rep. 2013;15(3):224–31. https://doi.org/10.1007/s11906-013-0334-7.CrossRefPubMed

26.

Hall JE, Brands MW, Dixon WN, Smith MJ. Obesity-induced hypertension. renal function and systemic hemodynamics. Hypertension. 1993;22(3):292–9. https://doi.org/10.1161/01.HYP.22.3.292.CrossRefPubMed

27.

Hamdani G, Flynn JT, Daniels S, Falkner B, Hanevold C, Ingelfinger J, Lande MB, et al. Ambulatory blood pressure monitoring tolerability and blood pressure status in adolescents: The SHIP AHOY Study. Blood Press Monit. 2019;24(1):12–7. https://doi.org/10.1097/MBP.0000000000000354.CrossRefPubMedPubMedCentral

28.

Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF, Avila Edwards KC, et al. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. Pediatrics. 2023;151:e2022060640. https://doi.org/10.1542/peds.2022-060640.CrossRefPubMed

29.

Hansen HS, Froberg K, Hyldebrandt N, Nielsen JR. A controlled study of eight months of physical training and reduction of blood pressure in children: The odense schoolchild study. BMJ. 1991;303(6804):682–5. https://doi.org/10.1136/bmj.303.6804.682.CrossRefPubMedPubMedCentral

30.

Hassan MA, Zhou W, Ye M, He H, Gao Z. The effectiveness of physical activity interventions on blood pressure in children and adolescents: a systematic review and network meta-analysis. J Sport Health Sci. 2024;13(5):699–708. https://doi.org/10.1016/j.jshs.2024.01.004.CrossRefPubMedPubMedCentral

31.

Hendricks EdJ, Greenway FL, Westman EC, Gupta AK. Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity. Obesity. 2011;19(12):2351–60. https://doi.org/10.1038/oby.2011.94.CrossRefPubMed

32.

Irizarry KA, Brito V, Freemark M. Screening for metabolic and reproductive complications in obese children and adolescents. Pediatr Ann. 2014;43(9). https://doi.org/10.3928/00904481-20140825-07.

33.

Ivanko OH, Tovma AV, Patsera MV, Solyanyk OV, Krut OS. The levels of endothelin, renin, copeptin, testosterone, estradiol, osteocalcin and PIVKA-II in adolescents aged 17 years with newly diagnosed hypertension. Child’s Health. 2022;17(3):133–7.CrossRef

34.

Jordan J, Astrup A, Engeli S, Narkiewicz K, Day WW, Finer N. Cardiovascular effects of phentermine and topiramate: A new drug combination for the treatment of obesity. J Hypertens. 2014;32(6):1178–88. https://doi.org/10.1097/HJH.0000000000000145.CrossRefPubMedPubMedCentral

35.

Kario K, Hoshide S, Chia Y-C, Buranakitjaroen P, Siddique S, Shin J, Turana Y, et al. Guidance on ambulatory blood pressure monitoring: a statement from the HOPE Asia Network. J Clin Hypertens. 2021;23(3):411–21. https://doi.org/10.1111/jch.14128.CrossRef

36.

Katsimardou A, Imprialos K, Stavropoulos K, Sachinidis A, Doumas M, Athyros V. Hypertension in metabolic syndrome: novel insights. Curr Hypertens Rev. 2020;16(1):12–8. https://doi.org/10.2174/1573402115666190415161813.CrossRefPubMed

37.

Kelly AS, Auerbach P, Barrientos-Perez M, Gies I, Hale PM, Marcus C, Mastrandrea LD, Prabhu N, Arslanian S. A randomized, controlled trial of liraglutide for adolescents with obesity. N Engl J Med. 2020;382(22):2117–28. https://doi.org/10.1056/NEJMoa1916038.CrossRefPubMed

38.

Kelly AS, Bensignor MO, Hsia DS, Shoemaker AH, Shih W, Peterson C, Varghese S T, The Trial Investigators. Phentermine/topiramate treat adolesc obes. NEJM Evid. 2022;1(6):EVIDoa2200014. https://doi.org/10.1056/EVIDoa2200014.CrossRef

39.

Khan MA, Mathur K, Barraza G, Sin S, Yang CJ, Arens R, Sutton N, Mahgerefteh J. The relationship of hypertension with obesity and obstructive sleep apnea in adolescents. Pediatr Pulmonol. 2020;55(4):1020–7. https://doi.org/10.1002/ppul.24693.CrossRefPubMed

40.

Köchli S, Endes K, Steiner R, Engler L, Infanger D, Schmidt-Trucksäss A, Zahner L, Hanssen H. Obesity, high blood pressure, and physical activity determine vascular phenotype in young children: The EXAMIN YOUTH study. Hypertension. 2019;73(1):153–61. https://doi.org/10.1161/HYPERTENSIONAHA.118.11872.CrossRefPubMed

41.

Kolanowski W, Ługowska K, Trafialek J. Increased physical activity at school benefits arterial blood pressure in children-a prospective follow-up cohort study. Int J Environ Res Public Health. 2022;19(8):4662. https://doi.org/10.3390/ijerph19084662.CrossRefPubMedPubMedCentral

42.

Label: QSYMIA- Phentermine and Topiramate Capsule, Extended Release. Package Insert. Vivus, LLC. 2023. December 11, 2023. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40dd5602-53da-45ac-bb4b-15789aba40f9.

43.

Leary SD, Ness AR, Smith GD, Mattocks C, Deere K, Blair SN, Riddoch C. Physical activity and blood pressure in childhood: findings from a population-based study. Hypertension. 2008;51(1):92–8. https://doi.org/10.1161/HYPERTENSIONAHA.107.099051.CrossRefPubMed

44.

Michael LA, Kirstine B-F, Colhoun HM, John D, Emerson SS, Sille E, Søren H-L, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221–32. https://doi.org/10.1056/NEJMoa2307563.CrossRef

45.

Litwin M. It is time for microcirculation. Hypertension. 2020;76(2):327–9. https://doi.org/10.1161/HYPERTENSIONAHA.120.15471.CrossRefPubMed

46.

Lona G, Endes K, Köchli S, Infanger D, Zahner L, Hanssen H. Retinal vessel diameters and blood pressure progression in children. Hypertension. 2020;76(2):450–7. https://doi.org/10.1161/HYPERTENSIONAHA.120.14695.CrossRefPubMed

47.

Mărginean CO, Meliţ LE, Ghiga DV, Mărginean MO. Early inflammatory status related to pediatric obesity. Front Pediatr. 2019;7(June):241. https://doi.org/10.3389/fped.2019.00241.CrossRefPubMedPubMedCentral

48.

Mcmurray RG, Harrell JS, Bangdiwala SI, Bradley CB, Deng S, Levine A. A school-based intervention can reduce body fat and blood pressure in young adolescents. J Adolesc Health. 2002;31(2):125–32. https://doi.org/10.1016/S1054-139X(02)00348-8.CrossRefPubMed

49.

Melson E, Ashraf U, Papamargaritis D, Davies MJ. What Is the Pipeline for Future Medications for Obesity? Int J Obes (2005). 2024. https://doi.org/10.1038/s41366-024-01473-y.

50.

Movahed M-R, Bates S, Strootman D, Sattur S. Obesity in adolescence is associated with left ventricular hypertrophy and hypertension. Echocardiogr (Mount Kisco, NY). 2011;28(2):150–3. https://doi.org/10.1111/j.1540-8175.2010.01289.x.CrossRef

51.

Ng CH, Wong ZY, Chew NWS, Chan KE, Xiao J, Sayed N, Lim WH, et al. Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality. Front Cardiovasc Med. 2022;9(August):942753. https://doi.org/10.3389/fcvm.2022.942753.CrossRefPubMedPubMedCentral

52.

Niiranen TJ, McCabe EL, Larson MG, Henglin M, Lakdawala NK, Vasan RS, Cheng S. Heritability and risks associated with early onset hypertension: multigenerational, prospective analysis in the framingham heart study. BMJ (Clinical Research Ed). 2017;357(May): j1949. https://doi.org/10.1136/bmj.j1949.CrossRefPubMed

53.

Obita G, Alkhatib A. Disparities in the prevalence of childhood obesity-related comorbidities: a systematic review. Front Public Health. 2022;10(July):923744. https://doi.org/10.3389/fpubh.2022.923744.CrossRefPubMedPubMedCentral

54.

Ogden CL, Fryar CD, Martin CB, Freedman DS, Carroll MD, Qiuping Gu, Hales CM. Trends in obesity prevalence by race and hispanic origin—1999-2000 to 2017–2018. JAMA. 2020;324(12):1208. https://doi.org/10.1001/jama.2020.14590.CrossRefPubMedPubMedCentral

55.

Okoli A, Hanlon EC, Brady MJ. The relationship between sleep, obesity, and metabolic health in adolescents – a review. Curr Opin Endocr Metab Res. 2021;17(April):15–9. https://doi.org/10.1016/j.coemr.2020.10.007.CrossRefPubMed

56.

Ostchega Y, Hughes JP, Prineas RJ, Zhang G, Nwankwo T, Chiappa MM. Mid-arm circumference and recommended blood pressure cuffs for children and adolescents aged between 3 and 19 Years: data from the national health and nutrition examination survey, 1999–2010. Blood Press Monit. 2014;19(1):26–31. https://doi.org/10.1097/MBP.0000000000000008.CrossRefPubMed

57.

Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the american heart association council on high blood pressure research. Circulation. 2005;111(5):697–716. https://doi.org/10.1161/01.CIR.0000154900.76284.F6.CrossRefPubMed

58.

Rajjo T, Almasri J, Nofal AA, Farah W, Alsawas M, Ahmed AT, Mohammed K, et al. The association of weight loss and cardiometabolic outcomes in obese children: systematic review and meta-regression. J Clin Endocrinol Metab. 2017;102(3):758–62. https://doi.org/10.1210/jc.2016-2575.CrossRefPubMed

59.

Redon J, Seeman T, Pall D, Suurorg L, Kamperis K, Erdine S, Wühl E, Mancia G. Narrative update of clinical trials with antihypertensive drugs in children and adolescents. Front Cardiovasc Med. 2022. 9(November). https://doi.org/10.3389/fcvm.2022.1042190.

60.

Reinehr T, De Sousa G, Toschke AM, Andler W. Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention 1,2. Am J Clin Nutr. 2006;84(3):490–6. https://doi.org/10.1093/ajcn/84.3.490.CrossRefPubMed

61.

Research, Center for Drug Evaluation and. 2022. FDA Approves Treatment for Chronic Weight Management in Pediatric Patients Aged 12 Years and Older. FDA, June. https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-chronic-weight-management-pediatric-patients-aged-12-years-and-older.

62.

Riley M, Hernandez AK, Kuznia AL. High blood pressure in children and adolescents. Am Fam Physician. 2018;98(8):486–94.PubMed

63.

Salam RA, Padhani ZA, Das JK, Shaikh AY, Hoodbhoy Z, Jeelani SM, Lassi ZS, Bhutta ZA. Effects of lifestyle modification interventions to prevent and manage child and adolescent obesity: a systematic review and meta-analysis. Nutrients. 2020;12(8):2208. https://doi.org/10.3390/nu12082208.CrossRefPubMedPubMedCentral

64.

Seravalle G, Grassi G. Obesity and hypertension. Pharmacol Res. 2017;122(August):1–7. https://doi.org/10.1016/j.phrs.2017.05.013.CrossRefPubMed

65.

Shapiro DJ, Hersh AL, Cabana MD, Sutherland SM, Patel AI. Hypertension screening during ambulatory pediatric visits in the united states, 2000–2009. Pediatrics. 2012;130(4):604–10. https://doi.org/10.1542/peds.2011-3888.CrossRefPubMed

66.

Sharma AK, Metzger DL, Rodd CJ. Prevalence and severity of high blood pressure among children based on the 2017 american academy of pediatrics guidelines. JAMA Pediatr. 2018;172(6):557. https://doi.org/10.1001/jamapediatrics.2018.0223.CrossRefPubMedPubMedCentral

67.

Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998;31(1):409–14. https://doi.org/10.1161/01.HYP.31.1.409.CrossRefPubMed

68.

Skinner AC, Staiano AE, Armstrong SC, Barkin SL, Hassink SG, Moore JE, Savage JS, et al. Appraisal of clinical care practices for child obesity treatment. Part II: comorbidities. Pediatrics. 2023;151(2):e2022060643. https://doi.org/10.1542/peds.2022-060643.CrossRefPubMed

69.

Srivastava G, Fox CK, Kelly AS, Jastreboff AM, Browne AF, Browne NT, Pratt JSA, et al. Clinical considerations regarding the use of obesity pharmacotherapy in adolescents with obesity. Obesity. 2019;27(2):190–204. https://doi.org/10.1002/oby.22385.CrossRefPubMed

70.

Styne DM, Arslanian SA, Connor EL, Farooqi IS, Hassan Murad M, Silverstein JH, Yanovski JA. Pediatric obesity—assessment, treatment, and prevention: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2017;102(3):709–57. https://doi.org/10.1210/jc.2016-2573.CrossRefPubMedPubMedCentral

71.

Su S, Wang X, Pollock JS, Treiber FA, Xiaojing Xu, Harold Snieder W, McCall V, Stefanek M, Harshfield GA. Adverse childhood experiences and blood pressure trajectories from childhood to young adulthood: the georgia stress and heart study. Circulation. 2015;131(19):1674–81. https://doi.org/10.1161/CIRCULATIONAHA.114.013104.CrossRefPubMedPubMedCentral

72.

Turer CB, Brady TM, de Ferranti SD. Obesity, hypertension, and dyslipidemia in childhood are key modifiable antecedents of adult cardiovascular disease: a call to action. Circulation. 2018;137(12):1256–9. https://doi.org/10.1161/CIRCULATIONAHA.118.032531.CrossRefPubMedPubMedCentral

73.

Vasunta R-L, Antero Kesäniemi Y, Ylitalo AS, Ukkola OH. High ambulatory blood pressure values associated with non-alcoholic fatty liver in middle-aged adults. J Hypertens. 2012;30(10):2015–9. https://doi.org/10.1097/HJH.0b013e3283576faf.CrossRefPubMed

74.

Viner RM, Hsia Y, Tomsic T, Wong ICK. Efficacy and safety of anti-obesity drugs in children and adolescents: systematic review and meta-analysis. Obes Rev. 2010;11(8):593–602. https://doi.org/10.1111/j.1467-789X.2009.00651.x.CrossRefPubMed

75.

Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics—2021 update: a report from the american heart association. Circulation. 2021; 143(8). https://doi.org/10.1161/CIR.0000000000000950.

76.

Weghuber D, Barrett T, Barrientos-Pérez M, Gies I, Hesse D, Jeppesen OK, Kelly AS, Mastrandrea LD, Sørrig R, Arslanian S. Once-weekly semaglutide in adolescents with obesity. N Engl J Med. 2022;387(24):2245–57. https://doi.org/10.1056/NEJMoa2208601.CrossRefPubMedPubMedCentral

77.

Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553–64. https://doi.org/10.1111/dom.14725.CrossRefPubMedPubMedCentral

78.

Wühl Elke. Hypertension in Childhood Obesity. Acta Paediatrica (Oslo, Norway: 1992). 2019;108(1):37–43. https://doi.org/10.1111/apa.14551.CrossRefPubMed

79.

Yang Q, Zhang Z, Kuklina EV, Fang J, Ayala C, Hong Y, Loustalot F, et al. Sodium intake and blood pressure among US children and adolescents. Pediatrics. 2012;130(4):611. https://doi.org/10.1542/peds.2011-3870.CrossRefPubMed

Title: Diagnosis and Management of Hypertension in Adolescents with Obesity
Authors: Shradha M. Chhabria
Jared LeBron
Sarah D. Ronis
Courtney E. Batt
Publication date: 30-07-2024
Publisher: Springer US
Keywords: Obesity
Obesity
Hypertension
Hypertension
Published in: Current Cardiovascular Risk Reports / Issue 8-9/2024
Print ISSN: 1932-9520
Electronic ISSN: 1932-9563
DOI: https://doi.org/10.1007/s12170-024-00740-x

Navigating neuroimaging in Alzheimer disease care

Springer Medicine

Diagnosis and Management of Hypertension in Adolescents with Obesity

Abstract

Purpose of Review

Recent Findings

Summary

Other articles of this Issue 8-9/2024

Keynote series | Spotlight on menopause

A quick guide to ECGs

Navigating neuroimaging in Alzheimer disease care

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Keynote series | Spotlight on menopause

A quick guide to ECGs